Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin vs Metformin for Antipsychotic-Induced Weight Gain
NCT07342764Phase 4Not yet recruiting
- Sponsor
- Sultan Qaboos University
- Start
- Sep 2026
- Primary completion
- Nov 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin in antipsychotic-induced weight gain (AIWG), sponsored by Sultan Qaboos University. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
dapagliflozin
03
Conditions
antipsychotic-induced weight gain (AIWG)
Beyond the preview
Go deeper on NCT07342764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07342764.